Vintage 1950s illustration of a gold and diamond wedding ring set in a presentation box; screen … More
In an era where marriage has long been lauded as a linchpin of mental and emotional well-being, emerging research is disrupting the narrative. A comprehensive new study from the National Alzheimer’s Coordinating Center (NACC) suggests that remaining unmarried—whether by choice or by circumstance—may actually protect…
News Source: www.forbes.com
Qatar has expressed its “strong condemnation” of recent media reports …
News Source: www.alquds.com
There are angry reactions from world leaders as the US announces tariffs on all imports.
United States President Donald Trump has called it “Liberation Day”, but world leaders say his new round of tariffs is likely to trigger a global trade war.
The White House announced the tariff rates will vary depending on the country, but nearly all nations will ultimately be affected.
The move has led to fury in China, dismay in Europe and confusion around the globe.
Trump says the tariffs are…
News Source: www.aljazeera.com
The drug fosdenopterin/rcPMP considerably improves the chances of survival and developmental progress in infants with molybdenum cofactor deficiency (MoCD type A), a rare and life-threatening genetic condition causing an inborn error in metabolism. This was shown in a clinical study recently published by an international research team led by Professor Dr Günter Schwarz from the Institute of Biochemistry at the University of Cologne. MoCD type A is a very rare disease. It affects around one…
News Source: www.sciencedaily.com
University of Calgary researchers say if you’ve had a minor stroke or transient ischemic attack (TIA), you remain at high risk of having another, more severe stroke for several years thereafter.
A lot of focus has been put on preventing stroke in the first 90-days post-TIA or minor stroke, which is when a person is at the highest risk of a second stroke. However, what we’re seeing in this study is that the risk continues and remains high for at least the next decade,” says Dr. Faizan Khan,…
News Source: www.sciencedaily.com
In the fight against bacterial pathogens, researchers are combining vaccination with targeted colonisation of the intestine by harmless microorganisms. This approach could potentially mark a turning point in the antibiotics crisis.
The issue of intestinal bacteria is a complex one. On the one hand, we are dependent on the microorganisms because they are the ones that digest the food in our intestine. On the other hand, there are also numerous pathogens present among the bacteria. Some of…
News Source: www.sciencedaily.com
Most of the time, the intestinal immune system can recognize friend from foe, tolerating myriad foods while destroying disease-causing invaders. But for approximately 30 million Americans with food allergies — including 4 million children — immune cells mistakenly identify food as a threat, triggering potentially life-threatening reactions.
Now, researchers at Washington University School of Medicine in St. Louis have identified, in mice, that essential immune cells in the intestine…
News Source: www.sciencedaily.com
Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer. These particles can be targeted directly to tumors, where they release their payload while avoiding many of the side effects of traditional chemotherapy.
Over the past decade, MIT Institute Professor Paula Hammond and her students have created a variety of these particles using a technique known as layer-by-layer assembly. They’ve shown that the particles can…
News Source: www.sciencedaily.com
A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills. An article that describes the new platform was published in the April 3online issue of the journal PLOS Computational Biology.
Developed by a multi-institutional team that was led by Icahn School of Medicine at Mount Sinai investigators as part of the National Institutes of…
News Source: www.sciencedaily.com
A team of researchers led by Dr. KIM V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics. Their study, recently published in Science, provides the first comprehensive understanding of how mRNA vaccines are delivered, processed, and degraded within cells — a breakthrough that could pave the way for more effective vaccines and RNA-based treatments.
News Source: www.sciencedaily.com